Atlas Trials

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Clinical trial NCT02149173 · TERMINATED

Trial details

NCT number
NCT02149173
Sponsor
University of Washington
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
Start date
2010-09-15
Primary completion
2018-12-27
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.